Related Experiment Video
Updated: Aug 12, 2025
Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
Published on: February 12, 2019
Extracellular vesicles: Targeting the heart
Xin Yin1,2,3, Li-Hong Jiang2,3
1Faculty of Life Sciences and Technology, Kunming University of Science and Technology, Kunming, China.
Insights
Extracellular vesicles (EVs) show promise for treating myocardial infarction, but face challenges in targeting the heart. This review explores strategies to improve EV heart-targeting efficiency for better cell-free therapy.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Research
Background:
- Cardiovascular diseases are a leading cause of global mortality, with myocardial infarction being a primary concern.
- Extracellular vesicles (EVs), including exosomes, are emerging as a potential cell-free therapeutic approach for myocardial infarction.
- Current limitations include low cardiac targeting efficiency and short plasma half-life, hindering clinical application.
Purpose of the Study:
- To review current strategies for enhancing the heart-targeting efficiency of extracellular vesicles.
- To discuss the challenges and opportunities associated with EV-based myocardial infarction therapy.
- To provide insights for developing effective heart-targeting strategies.
Main Methods:
- Review of existing literature on extracellular vesicle (EV) modifications and delivery systems.
- Analysis of strategies to improve EV targeting, including surface modification, absorption suppression, enhanced cellular uptake, and hydrogel patches.
- Discussion of current research and future directions in EV therapy for myocardial infarction.
Main Results:
- Four main strategies have been developed to enhance EV heart-targeting efficiency.
- These strategies involve modifying EV surfaces, reducing non-target absorption, improving target cell uptake, and using hydrogel patches.
- Significant progress has been made, but challenges remain for clinical translation.
Conclusions:
- Extracellular vesicle therapy holds significant potential for treating myocardial infarction.
- Overcoming low heart-targeting efficiency and short plasma half-life is crucial for clinical success.
- Further research into optimized EV delivery and targeting strategies is warranted.
Abstract:
Cardiovascular diseases rank the highest incidence and mortality worldwide. As the most common type of cardiovascular disease, myocardial infarction causes high morbidity and mortality. Recent studies have revealed that extracellular vesicles, including exosomes, show great potential as a promising cell-free therapy for the treatment of myocardial infarction. However, low heart-targeting efficiency and short plasma half-life have hampered the clinical translation of extracellular vesicle therapy. Currently, four major types of strategies aiming at enhancing target efficiency have been developed, including modifying EV surface, suppressing non-target absorption, increasing the uptake efficiency of target cells, and utilizing a hydrogel patch. This presented review summarizes the current research aimed at EV heart targeting and discusses the challenges and opportunities in EV therapy, which will be beneficial for the development of effective heart-targeting strategies.
More Related Videos
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
05:30Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
